Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 25.8 | 0.0 | 4.7 | 11.2 | 11.3 | 15.9 | 36.4 | 47.3 |
Revenue growth | | -100.0% | -58.1% | -0.1% | -29.3% | -56.3% | -23.0% | 4737.4% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.7 | 0.0 | 0.0 |
Gross profit | 25.8 | 0.0 | 4.7 | 11.2 | 10.2 | 15.3 | 36.4 | 47.3 |
Gross margin | 100.0% | | 100.0% | 100.0% | 90.2% | 95.9% | 100.0% | 100.0% |
Selling, general and administrative | | | | | | | | |
Research and development | 28.7 | 19.5 | 20.0 | 15.6 | 22.3 | 27.6 | 34.0 | 45.0 |
General and administrative | 10.8 | 7.6 | 7.6 | 9.8 | 12.2 | 12.8 | 13.9 | 13.4 |
EBIT | -13.7 | -27.0 | -22.9 | -14.2 | -24.3 | -25.1 | -11.4 | -11.1 |
EBIT margin | -53.2% | | -486.2% | -125.9% | -215.7% | -157.9% | -31.3% | -23.4% |
Pre-tax income | -15.5 | -29.2 | -22.7 | -13.8 | -23.4 | -24.6 | -10.9 | -10.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -15.5 | -29.2 | -22.7 | -13.8 | -23.4 | -24.6 | -10.9 | -10.8 |
Net margin | -60.1% | | -482.4% | -122.6% | -207.8% | -154.6% | -29.9% | -22.7% |
|
Diluted EPS | ($0.16) | ($0.39) | ($0.33) | ($0.22) | ($0.37) | ($0.39) | ($0.18) | ($0.20) |
Shares outstanding (diluted) | 99.0 | 74.8 | 69.7 | 62.8 | 62.6 | 62.5 | 59.8 | 52.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|